Citation Impact
Citing Papers
SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
2019 StandoutNobel
Microbiota in health and diseases
2022 Standout
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Alzheimer’s disease and gut microbiota
2016
Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus
2000
Pathogenic microbes, the microbiome, and Alzheimer’s disease (AD)
2014
Interactions between the microbiota, immune and nervous systems in health and disease
2017 Standout
Multiple phases of chondrocyte enlargement underlie differences in skeletal proportions
2013 StandoutNature
IgE Mediates Killing of Intracellular Toxoplasma gondii by Human Macrophages through CD23-Dependent, Interleukin-10 Sensitive Pathway
2011
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
2005 Standout
IgE and mast cells in allergic disease
2012 Standout
Lean Body Mass as a Predictor of Drug Dosage
1994
Antibiotic resistance of bacterial biofilms
2010 Standout
Structural and functional features of central nervous system lymphatic vessels
2015 StandoutNature
Antibody therapy of cancer
2012 Standout
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
2011 Standout
The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D)
2012
Gut microbiome alterations in Alzheimer’s disease
2017 Standout
Acute kidney injury
2021 Standout
Clinical-radiological features of fractures in premature infants – a review
2007
Hepatic cytochrome P450 3A drug metabolism is reduced in cancer patients who have an acute-phase response
2002
The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication
2020 Standout
Cerebral Arterial Pulsation Drives Paravascular CSF–Interstitial Fluid Exchange in the Murine Brain
2013 Standout
The Glymphatic System: A Beginner’s Guide
2015 Standout
Hypophosphatasia and the Role of Alkaline Phosphatase in Skeletal Mineralization*
1994
Multiplicity of cerebrospinal fluid functions: New challenges in health and disease
2008
Tolerance, pharmacokinetics and efficacy of once daily amikacin for treatment of Pseudomonas aeruginosa pulmonary exacerbations in cystic fibrosis patients
1996
Kynurenines in the CNS: recent advances and new questions
2012
Infection, systemic inflammation, and Alzheimer's disease
2015
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
2014 Standout
Update on Key Emerging Challenges in Cystic Fibrosis
2014 Standout
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
The Evaluation of Suspected Child Physical Abuse
2015 Standout
Intracellular Retention and Degradation of Tissue-Nonspecific Alkaline Phosphatase with a Gly317→Asp Substitution Associated with Lethal Hypophosphatasia
1998 StandoutNobel
Can we vaccinate against depression?
2012
Common mutations F310L and T1559del in the tissue-nonspecific alkaline phosphatase gene are related to distinct phenotypes in Japanese patients with hypophosphatasia
2005 StandoutNobel
Interspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugs
2011
Outcome measures for clinical trials in cystic fibrosis Summary of a Cystic Fibrosis Foundation Consensus Conference
1994
The role of inflammation in depression: from evolutionary imperative to modern treatment target
2015 Standout
The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial
2010
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Admission Screening for Secondhand Tobacco Smoke Exposure
2012
Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment
2009 Standout
Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization
2002 Standout
Gut Microbiota is Altered in Patients with Alzheimer’s Disease
2018 Standout
Monoclonal Antibodies for Cancer Therapy
2012 StandoutNobel
The role of alkaline phosphatase in mineralization
2007 Standout
Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis
2014 Standout
Single-nanometer iron oxide nanoparticles as tissue-permeable MRI contrast agents
2021 StandoutNobel
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
Lung Transplantation in Cystic Fibrosis
1998
A key role for membrane transporter NKCC1 in mediating chondrocyte volume increase in the mammalian growth plate
2010
Neonatal Acute Kidney Injury
2015
Vascular Calcification
2006 Standout
Lung Infections Associated with Cystic Fibrosis
2002 Standout
Possible interference between tissue-non-specific alkaline phosphatase with an Arg54→Cys substitution and a counterpart with an Asp277→Ala substitution found in a compound heterozygote associated with severe hypophosphatasia
2000 StandoutNobel
Works of J Prandota being referenced
Possible Pathomechanisms of Sudden Infant Death Syndrome
2004
High doses of furosemide in children with acute renal failure
1991
Pharmacokinetic, biliary excretion, and metabolic studies of14C-furosemide in the rat
1991
Recurrent Headache as the Main Symptom of Acquired Cerebral Toxoplasmosis in Nonhuman Immunodeficiency Virus-infected Subjects With no Lymphadenopathy
2007
Clinical Pharmacology of Furosemide in Children: A Supplement
2001
Drug disposition in cystic fibrosis
1987
Clinical Pharmacokinetics of Changes in Drug Elimination in Children
1985
Binding of erythromycin base to human plasma proteins.
1980
Drug disposition in cystic fibrosis: progress in understanding pathophysiology and pharmacokinetics.
1987
Possible Link Between Toxoplasma Gondii and the Anosmia Associated With Neurodegenerative Diseases
2014
[Hypophosphatasia with normal urinary phosphoethanolamine in a 22-month-old girl].
1980
Important role of proinflammatory cytokines/other endogenous substances in drug-induced hepatotoxicity: depression of drug metabolism during infections/inflammation states, and genetic polymorphisms of drug-metabolizing enzymes/cytokines may markedly contribute to this pathology.
2005